Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
Informe sobre poblaciones clave.
Rappart sur les populations clés.
On the road to ending TB
Highlights from the 30 highest TB burden countries
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Towards gender - transformative HIV and TB responses
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...men characteristics corresponding to the needs of end-users.
more
Indicators are a representation of reality. They are just numbers on a piece of paper or on a computer screen, but they stand for something far greater – the success of your project. Indicators are usually defined in the context of project planning and show something about or give an indication of... progress towards realising the project goal, without being complete or comprehensive. Of course, there could be other representations of this reality, such as stories (Dart and Davies, 2003) or drawings (Feuerstein, 1986) or photographs (Tijm et al, 2011). However, indicators are a widely accepted way of representing what is being achieved in a programme or project.
more
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Regional Analysis. WPSAR Vol 7, No 2, 2016 | doi: 10.5365/wpsar.2015.6.4.010
A Systematic Review and Meta-analysis
Clinical Infectious Diseases® 2016;62(12):1586–94
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...guidelines.
The 2016 interim update to the 2015 BHIVA antiretroviral guidelines has been published online to include tenofovir-alafenamide/emtricitabine as a preferred NRTI backbone for first-line therapy. Changes were based on new data and the consensus opinion of the writing committee. All changes to the guideline are highlighted and include updates to the chronic kidney disease and bone disease sections of special populations and some small changes to managing virological failure.
The 2019 interim statement provides updated advice on treatment with two-drug regimens
more
World Health Organization Department of Reproductive Health and Research
Brocher Foundation, Hermance, Geneva, Switzerland, 27–29 April 2016